Skip to main content
Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.25
-0.54 (-7.95%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Pulmonx Revenue

Pulmonx had revenue of $20.39M in the quarter ending September 30, 2024, with 15.39% growth. This brings the company's revenue in the last twelve months to $79.30M, up 22.34% year-over-year. In the year 2023, Pulmonx had annual revenue of $68.68M with 27.98% growth.

Revenue (ttm)
$79.30M
Revenue Growth
+22.34%
P/S Ratio
3.32
Revenue / Employee
$284,237
Employees
279
Market Cap
244.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202368.68M15.01M27.98%
Dec 31, 202253.66M5.25M10.84%
Dec 31, 202148.42M15.68M47.91%
Dec 31, 202032.73M138.00K0.42%
Dec 31, 201932.60M12.59M62.94%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
High Tide 370.02M
Poseida Therapeutics 88.46M
Enanta Pharmaceuticals 71.96M
SOPHiA GENETICS 64.94M
Precigen 4.39M
Lyell Immunopharma 54.00K
Revenue Rankings

LUNG News

More News